Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Antoine Deslandes"'
Autor:
Antoine Deslandes, Clémentine Calba, Sarah Mahdjoub, Aurélien Zhu-Soubise, Damian Mathey, Alexis Ardoin
Publikováno v:
Journal of Infection and Public Health, Vol 14, Iss 11, Pp 1733-1738 (2021)
Background: The 2020 COVID-19 pandemic led to a strict lockdown in France from March 17 to May 11, 2020. After the lockdown, the French strategy to mitigate the impact of SARS-CoV-2 relied partly on investigations of all confirmed cases. Monitoring c
Externí odkaz:
https://doaj.org/article/de5ad89f371d42c89315f3ea1a3341f8
Autor:
Alexandra Lomont, Marouane Boubaya, Warda Khamis, Antoine Deslandes, Hugues Cordel, Delphine Seytre, Chakib Alloui, Célie Malaure, Nicolas Bonnet, Etienne Carbonnelle, Yves Cohen, Hilario Nunes, Olivier Bouchaud, Jean-Ralph Zahar, Yacine Tandjaoui-Lambiotte, AIRMIC study group:, Frédéric Le Gal, Frédéric Mechai, Typhaine Billard-Pomares, Nerville-Emmanuel Gordien, Johann Cailhol, Sophie Brun, Athenaïs Gerber, Paul Deny
Publikováno v:
ERJ Open Research, Vol 6, Iss 4 (2020)
Background The coronavirus disease 2019 (COVID-19) outbreak is a primary global concern, and data are lacking concerning risk of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination. Objective To identify ris
Externí odkaz:
https://doaj.org/article/ea44ab52a0d1413a95a400332e8f3a38
Autor:
David E. Coutant, David W. Boulton, Upendra P. Dahal, Antoine Deslandes, Christine Grimaldi, Joao N.S. Pereira, Carolina Säll, Hetal Sarvaiya, Hilmar Schiller, Guoying Tai, Kenichi Umehara, Yang Yuan, Shannon Dallas
Publikováno v:
Clinical pharmacology and therapeutics.
Typically, therapeutic proteins (TPs) have a low risk for eliciting meaningful drug interactions (DIs). However, there are select instances where TP drug interactions (TP-DIs) of clinical concern can occur. This white paper discusses the various type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff143ea497f2f1f7a99bae1fc026c1ca
https://pubmed.ncbi.nlm.nih.gov/36477720
https://pubmed.ncbi.nlm.nih.gov/36477720
Autor:
Chakib-Ahmed Alloui, E. Carbonnelle, A. Jacolot, Delphine Seytre, Isabelle Grall, Jean-Ralph Zahar, Ségolène Brichler, Antoine Deslandes, Julie Chappe, Yacine Tandjaoui-Lambiotte, Alexandra Lomont
Publikováno v:
Journal of Infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef8adb7dcf7eeaa64645d4efa1f4fea3
https://doi.org/10.1016/j.jinf.2020.08.044
https://doi.org/10.1016/j.jinf.2020.08.044
Autor:
Chao Han, Marque Todd, Chunze Li, Frank R. Brennan, Zheng Yang, Sherri Dudal, Wendy J. Bailey, Yingxue Chen, Nagendra V. Chemuturi, Kapil Mayawala, Lise I. Loberg, Antoine Deslandes, Clarke David O, Michael W. Leach, Mark Rogge
Publikováno v:
Clinical Pharmacology & Therapeutics. 109:1395-1416
Various approaches to first-in-human (FIH) starting dose selection for new molecular entities (NMEs) are designed to minimize risk to trial subjects. One approach uses the minimum anticipated biological effect level (MABEL), which is a conservative m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9b9ae8f92d0d96e2c0c7071ecc9d48d
https://doi.org/10.1002/cpt.2009
https://doi.org/10.1002/cpt.2009
Autor:
Sarah Mahdjoub, Aurélien Zhu-Soubise, Alexis Ardoin, Antoine Deslandes, Clémentine Calba, Damian Mathey
Publikováno v:
Journal of Infection and Public Health
Journal of Infection and Public Health, Vol 14, Iss 11, Pp 1733-1738 (2021)
Journal of Infection and Public Health, Vol 14, Iss 11, Pp 1733-1738 (2021)
Background The 2020 COVID-19 pandemic led to a strict lockdown in France from March 17 to May 11, 2020. After the lockdown, the French strategy to mitigate the impact of SARS-CoV-2 relied partly on investigations of all confirmed cases. Monitoring co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c03bb71bdb8b366c2d2dfb42e01a6c0
http://europepmc.org/articles/PMC8493733
http://europepmc.org/articles/PMC8493733
Autor:
Chakib Alloui, Ségolène Brichler, Yves Cohen, E. Carbonnelle, Y. Tandjaoui-Lambotte, Antoine Deslandes, V. Berti, Jean-Ralph Zahar
Publikováno v:
International Journal of Antimicrobial Agents
Highlights • SARS-CoV-2 was already spreading in France in late December 2019, 1 month before the first official cases in the country. • Early community spreading changes our knowledge of the COVID-19 epidemic. • This new case changes our under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::082a679425f3a8a6db2fce3be92487b5
https://doi.org/10.1016/j.ijantimicag.2020.106006
https://doi.org/10.1016/j.ijantimicag.2020.106006
Autor:
Yan Q. Xiong, Wessam Abdel Hady, Astrid Rey, Michael R. Yeaman, Antoine Deslandes, Hans-Henrik Kristensen, Arnold S. Bayer, Laurent Fraisse
Publikováno v:
Antimicrobial Agents and Chemotherapy. 55:5325-5330
Cationic antimicrobial peptides (CAPs) play important roles in host immune defenses. Plectasin is a defensin-like CAP isolated from the saprophytic fungus Pseudoplectania nigrella . NZ2114 is a novel variant of plectasin with potent activity against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f923a36b6e7a1e11203898c6703e8419
https://doi.org/10.1128/aac.00453-11
https://doi.org/10.1128/aac.00453-11
Autor:
Johnny J. Yang, Weirong Wang, Nagendra Chemuturi, Ramaswamy A. Iyer, Eugenia Kraynov, Markus Walles, Priya Sriraman, David J Moore, Amita Datta-Mannan, Edit Tarcsa, Guangqing Xiao, Amrita V. Kamath, Enrique Escandón, Matthew Barfield, Michaela Bairlein, Antoine Deslandes, Dan A. Rock
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 44(5)
An antibody-drug conjugate (ADC) is a unique therapeutic modality composed of a highly potent drug molecule conjugated to a monoclonal antibody. As the number of ADCs in various stages of nonclinical and clinical development has been increasing, phar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b2b07ae1f5b94981708d2f7055083f9
https://pubmed.ncbi.nlm.nih.gov/26669328
https://pubmed.ncbi.nlm.nih.gov/26669328
Autor:
Antoine Deslandes
Publikováno v:
mAbs. 6(4)
Although there are currently more than 30 antibody-drug conjugates (ADC) in clinical development for the treatment of blood cancers and solid tumors, comparison of their clinical pharmacokinetics (PK) is challenging because of the large number of, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a23a1cd193e7fe056e0aaaddb97454
https://pubmed.ncbi.nlm.nih.gov/24852950
https://pubmed.ncbi.nlm.nih.gov/24852950